A cutting edge technology and significant opportunity for growth

Investor Relations

Investor Relations

We are an ophthalmic device company that has developed and is currently marketing a proprietary optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. Our lens, the Presbia Flexivue Microlens™, is a miniature lens designed to be surgically implanted in a patient’s eye to improve that patient’s ability to see objects at close distances. Our current strategy is to continue to commercialize the Presbia Flexivue Microlens™ in certain strategic countries where we currently have marketing approval and to continue to seek to obtain marketing approval in other key markets, including the United States. Our goal is to become a leading provider of corneal inlay presbyopia-correcting treatment worldwide.

Recent Releases

Upcoming Events

There are currently no events to display.